A comparative study of teriflunomide and dimethyl fumarate within the Swedish MS Registry.

Jan HillertJon A TsaiMona NouhiAnna GlaserTimothy Spelman

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2021)

This population-based real-world study reports similarities in treatment persistence, clinical effectiveness and quality of life outcomes between teriflunomide and dimethyl fumarate.

Keyphrases

randomized controlled trial
mass spectrometry
systematic review
multiple sclerosis
ms ms
emergency department
adipose tissue
metabolic syndrome
skeletal muscle
combination therapy
glycemic control